Your browser is unsupported and may have security vulnerabilities! Upgrade to a newer browser to experience this site in all it's glory.
Skip to main content

From | Friday 7 September 2018

The “finishing touches” are being put on RB’s £105m Science and Innovation Centre as jobs become available to work in the new facility.

Construction on the state-of-the-art centre is in its final stages, as the global health company prepares to move in before the end of 2018.

Almost 40 jobs are currently up for grabs at RB in Hull, in what R&D site lead Dr Bruce Charlesworth described as “an exciting time” for the company.

“The main thing for us has been getting the quality right. These are health care products which we will be developing in the centre, so it is critical everything is correct,” he said.

“In terms of the cough and cold portfolio, we will be working on Strepsils and Gaviscon in the new centre. Other brands include Nurofen, Optrex and Scholl Footcare will also be there."

Get the full story here.